Live Breaking News & Updates on David Worthylake

Research led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studies, reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast cancer cells synergistically. ....

Jone Garai , Janarthanan Jayawickramarajah , David Worthylake , Suresh Alahari , Lothar Lauterboeck , Jovanny Zabaleta , Mohammad Amin Zarandi , Maninder Khosla , Emily Henderson , Joseph Kissil , Qinglin Yang , Samuelc Okpechi , Dorota Wyczechowska , Hassan Yousefi , Jessie Guidry , Health New Orleans , Health New Orleans School Of Medicine , Tulane University , H Lee Moffitt Cancer Center , Fredg Brazda Foundation , Health New Orlean Schools Of Medicine , National Cancer Institute Diversity Set , New Orlean Schools , Graduate Studies , National Cancer Institute , Diversity Set ,